PDF herunterladen
CC BY-NC-ND 4.0 · Asian J Neurosurg 2021; 16(02): 355-362
DOI: 10.4103/ajns.AJNS_509_20
Original Article

Retrospective study and outcome predictor after microsurgical resection of cerebral arteriovenous malformations in Nepal

Prasanna Karki
Department of Neurosciences, Division of Neurosurgery, Nepal Mediciti Hospital, Lalitpur, Kathmandu
,
Gopal Sharma
Department of Neurosciences, Division of Neurosurgery, Nepal Mediciti Hospital, Lalitpur, Kathmandu
,
Sumit Joshi
Department of Neurosciences, Division of Neurosurgery, Nepal Mediciti Hospital, Lalitpur, Kathmandu
,
Prakash Paudel
Department of Neurosciences, Division of Neurosurgery, Nepal Mediciti Hospital, Lalitpur, Kathmandu
,
Damber Shah
Department of Neurosciences, Division of Neurosurgery, Nepal Mediciti Hospital, Lalitpur, Kathmandu
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
  Lizenzen und Reprints

Objective: The purpose of this study is to assess demographic, clinical, and morphological characteristics of patients with brain arteriovenous malformations (bAVMs). The relation of outcome using modified Ranklin Scale (mRS) at time of discharge, early and last follow ups with respect to various factors. Materials and Methods: Demographic data, arteriovenous malformation characteristics, and treatment outcomes were evaluated in 43 bAVMs treated with microsurgery between 2009 and 2019. For this series, 43 patients were retrospectively reviewed. A subgroup analysis for Spetzler-Martin grades (SMG) I/II, III, IV/V and III–V were performed. The mRS was used to assess functional outcomes. Results: Overall, mean age at diagnosis was 33 years (standard deviation = 19). Transient deficit, mRS deterioration and impaired functional outcome occurred less frequently in SMG I–II patients compared with Grade III–V patients combined (29% vs. 32% respectively, P = 0.00). All patients with SMG Grade I, Supplemented SMG Grade 2, 3, 4 and 6 had a mRS score of 2 or less at the last follow-up. Age was the only significant predictor of overall outcome after bAVM surgery on Chi-square test (P = 0.046), i.e: all patients <20 years had mRS score of 2 or less on last follow-up. Unfavorable outcome (mRS score of 3 or more than 3) level increased with higher grades in SMG on long term follow-up. Conclusion: The results of our case series of bAVM with SMG Grade I and Suplemented Grade 2, 3, 4 and even higher grade i.e., 6 can have excellent overall outcome after microsurgical resection. Association of factors which increases the grading system of bAVM like eloquence, deep venous drainage and increasing sizes did not correlate with the predicted unfavorable outcomes, whereas age of patients was a predictor of overall outcome. Although the small sample size of this study is a limitation, age of patient plays important role on the overall outcome.

Key-words:

Arteriovenous malformations - brain arteriovenous malformation - functional outcome - microsurgery - Spetzler-Martin grades

Financial support and sponsorship

Nil.




Publikationsverlauf

Eingereicht: 26. November 2020

Angenommen: 03. Februar 2021

Artikel online veröffentlicht:
16. August 2022

© 2021. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Solomon RA, Connolly ES. Arteriovenous malformations of the brain. N Engl J Med 2017;376:1859-66.
  • 2 Brown RD Jr., Wiebers DO, Torner JC, O'Fallon WM. Frequency of intracranial hemorrhage as a presenting symptom and subtype analysis: A population-based study of intracranial vascular malformations in Olmsted Country, Minnesota. J Neurosurg 1996;85:29-32.
  • 3 Friedlander RM. Clinical practice. Arteriovenous malformations of the brain. N Engl J Med 2007;356:2704-12.
  • 4 Al-Shahi R, Warlow C. A systematic review of the frequency and prognosis of arteriovenous malformations of the brain in adults. Brain 2001;124:1900-26.
  • 5 Burkhardt JK, Lasker GF, Winkler EA, Kim H, Lawton MT. Microsurgical resection of brain arteriovenous malformations in the elderly: Outcomes analysis and risk stratification. J Neurosurg 2018;129:1107-13.
  • 6 Ogilvy CS, Stieg PE, Awad I, Brown RD Jr, Kondziolka D, Rosenwasser R et al. Special Writing Group of the Stroke Council, American Stroke Association. AHA Scientific Statement: Recommendations for the management of intracranial arteriovenous malformations: A statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Stroke 2001;32:1458-71.
  • 7 Starke RM, Komotar RJ, Hwang BY, Fischer LE, Garrett MC, Otten ML, et al. Treatment guidelines for cerebral arteriovenous malformation microsurgery. Br J Neurosurg 2009;23:376-86.
  • 8 Ponce FA, Spetzler RF. Arteriovenous malformations: Classification to cure. Clin Neurosurg 2011;58:10-2.
  • 9 Mohr JP, Parides MK, Stapf C, Moquete E, Moy CS, Overbey JR, et al. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): A multicentre, non-blinded, randomised trial. Lancet 2014;383:614-21.
  • 10 Mohr JP, Overbey JR, Hartmann A, Kummer RV, Al-Shahi Salman R, Kim H, et al. Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): Final follow-up of a multicentre, non-blinded, randomised controlled trial. Lancet Neurol 2020;19:573-81.
  • 11 Abla AA, Rutledge WC, Seymour ZA, Guo D, Kim H, Gupta N, et al. A treatment paradigm for high-grade brain arteriovenous malformations: Volume-staged radiosurgical downgrading followed by microsurgical resection. J Neurosurg 2015;122:419-32.
  • 12 Pollock BE, Flickinger JC. Modification of the radiosurgery-based arteriovenous malformation grading system. Neurosurgery 2008;63:239-43.
  • 13 Davidson AS, Morgan MK. How safe is arteriovenous malformation surgery? A prospective, observational study of surgery as first-line treatment for brain arteriovenous malformations. Neurosurgery 2010;66:498-504.
  • 14 Kuhmonen J, Piippo A, Väärt K, Karatas A, Ishii K, Winkler P, et al. Early surgery for ruptured cerebral arteriovenous malformations. Acta Neurochir Suppl 2005;94:111-4.
  • 15 Pikus HJ, Beach ML, Harbaugh RE. Microsurgical treatment of arteriovenous malformations: Analysis and comparison with stereotactic radio- surgery. J Neurosurg 1998;88:641-6.
  • 16 Stapf C, Khaw AV, Sciacca RR, Hofmeister C, Schumacher HC, Pile-Spellman J, et al. Effect of age on clinical and morphological characteristics in patients with brain arteriovenous malformation. Stroke 2003;34:2664-9.
  • 17 van Beijnum J, van der Worp HB, Buis DR, Al-Shahi Salman R, Kappelle LJ, Rinkel GJ, et al. Treatment of brain arteriovenous malformations: A systematic review and meta-analysis. JAMA 2011;306:2011-9.
  • 18 Sanchez-Mejia RO, Chennupati SK, Gupta N, Fullerton H, Young WL, Lawton MT. Superior outcomes in children compared with adults after microsurgical resection of brain arteriovenous malformations. J Neurosurg 2006;105:82-7.
  • 19 Hartmann A, Mast H, Mohr JP, Koennecke HC, Osipov A, Pile-Spellman J, et al. Morbidity of intracranial hemorrhage in patients with cerebral arteriovenous malformation. Stroke 1998;29:931-4.
  • 20 Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg 1986;65:476-83.
  • 21 Ferch RD, Morgan MK. High-grade arteriovenous malformations and their management. J Clin Neurosci 2002;9:37-40.